These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11709759)
1. Development, acceptance, and use of immunologic correlates of protection in monitoring the effectiveness of combination vaccines. Edwards KM Clin Infect Dis; 2001 Dec; 33 Suppl 4():S274-7. PubMed ID: 11709759 [TBL] [Abstract][Full Text] [Related]
2. [Advances in vaccines and invasive disease in children]. Moraga Llop FA Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977 [No Abstract] [Full Text] [Related]
3. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067 [TBL] [Abstract][Full Text] [Related]
4. Serologic correlates of protection for evaluating the response to meningococcal vaccines. Balmer P; Borrow R Expert Rev Vaccines; 2004 Feb; 3(1):77-87. PubMed ID: 14761245 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [TBL] [Abstract][Full Text] [Related]
6. Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines. Käyhty H; Ahman H Clin Infect Dis; 2001 Dec; 33 Suppl 4():S292-8. PubMed ID: 11709762 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine. Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981 [TBL] [Abstract][Full Text] [Related]
13. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996 [TBL] [Abstract][Full Text] [Related]
14. Assessing efficacy of Haemophilus influenzae type b combination vaccines. Granoff DM Clin Infect Dis; 2001 Dec; 33 Suppl 4():S278-87. PubMed ID: 11709760 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR; Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896 [TBL] [Abstract][Full Text] [Related]
16. Immunization with the 7-valent conjugate pneumococcal vaccine: impact evaluation, continuing surveillance and future perspectives. Bechini A; Boccalini S; Bonanni P Vaccine; 2009 May; 27(25-26):3285-90. PubMed ID: 19200829 [TBL] [Abstract][Full Text] [Related]